US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

SNY

Sanofi (SNY)

Sanofi

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/19	02 : 23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
2024/11/15	14 : 59	GlobeNewswire Inc.	Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)	NASDAQ:SNY	Sanofi
2024/11/06	15 : 00	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis	NASDAQ:SNY	Sanofi
2024/10/29	06 : 56	PR Newswire (Canada)	L'immunisation par Beyfortus® pour protéger les nourrissons contre le VRS a commencé	NASDAQ:SNY	Sanofi
2024/10/29	06 : 54	PR Newswire (Canada)	Beyfortus® immunization to protect infants from RSV has begun	NASDAQ:SNY	Sanofi
2024/10/25	19 : 05	IH Market News	Capri Shares Crash 45% After Merger Block; Coursera Falls 18% on Lower Revenue Forecast	NASDAQ:SNY	Sanofi
2024/10/21	18 : 47	IH Market News	Spirit’s Stock Surges 56% on Refinancing; Starboard Invests in Kenvue; Cigna-Humana Merger Back in Negotiations	NASDAQ:SNY	Sanofi
2024/10/17	15 : 35	Business Wire	Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines	NASDAQ:SNY	Sanofi
2024/10/17	15 : 35	Business Wire	Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération	NASDAQ:SNY	Sanofi
2024/10/17	01 : 26	PR Newswire (US)	FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals	NASDAQ:SNY	Sanofi
2024/10/16	19 : 00	PR Newswire (US)	Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies	NASDAQ:SNY	Sanofi
2024/10/11	19 : 31	IH Market News	BP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and More	NASDAQ:SNY	Sanofi
2024/09/27	22 : 35	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD	NASDAQ:SNY	Sanofi
2024/09/27	20 : 00	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)	NASDAQ:SNY	Sanofi
2024/09/25	03 : 51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
2024/09/23	19 : 32	IH Market News	Apollo Eyes $5 Billion Investment in Intel; TSMC and Samsung Explore UAE Chip Projects, and More	NASDAQ:SNY	Sanofi
2024/09/20	20 : 45	GlobeNewswire Inc.	Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old	NASDAQ:SNY	Sanofi
2024/09/16	21 : 00	PR Newswire (US)	Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA	NASDAQ:SNY	Sanofi
2024/09/14	01 : 15	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)	NASDAQ:SNY	Sanofi
2024/09/12	15 : 37	Business Wire	Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers rares	NASDAQ:SNY	Sanofi
2024/09/12	15 : 37	Business Wire	Sanofi, RadioMedix, and Orano Med Announce Licensing Agreement on Next-Generation Radioligand Medicine for Rare Cancers	NASDAQ:SNY	Sanofi
2024/08/13	22 : 06	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SNY	Sanofi
2024/08/13	19 : 30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SNY	Sanofi
2024/08/13	19 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
2024/07/27	01 : 08	PR Newswire (Canada)	Le vaccin FluzoneMD Haute Dose Quadrivalent demeure le vaccin préférentiellement recommandé pour protéger les adultes de 65 ans et plus contre la grippe	NASDAQ:SNY	Sanofi
2024/07/27	00 : 17	PR Newswire (Canada)	Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza	NASDAQ:SNY	Sanofi
2024/07/25	19 : 19	IH Market News	Earnings Updates: Ford Shares Fall 13% on EPS Miss, Stellantis Down 6%, Viking Therapeutics Up 20%, Unilever Up 5%	NASDAQ:SNY	Sanofi
2024/07/11	05 : 10	PR Newswire (US)	Sanofi ships U.S. influenza vaccines for the 2024/25 season	NASDAQ:SNY	Sanofi
2024/07/09	19 : 54	IH Market News	BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News	NASDAQ:SNY	Sanofi
2024/06/27	06 : 30	GlobeNewswire Inc.	Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine	NASDAQ:SNY	Sanofi

Showing the most relevant articles for your search:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Yen

Bank of America

American Express

Gold vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約